The precious bodily fluid which laps at the shore of your brain is sometimes accessible for analysis, and can be an endless source of physiological amusement. It is represented by the topic "Interpretation of cerebrospinal fluid" from Section 2.0.8 in the second edition of the CICM Syllabus for the Second Part Examination, for which the candidates were expected to have knowledge of "relevant anatomy, principles and practice, interpretation, relevant guidelines and evidence, and controversies and risks". The reader who is preparing for their final CICM exams will recognise that most of these generic expectations will not apply to their preparation for SAQs on this topic, as historically the CSF questions have all taken the shape of "does this CSF look infected to you?", and expected the candidate to generate a list of differentials.
In summary:
Venkatesh, our former college head, has published a nice article about the various interesting qualities of CSF. In the article, one may find a nice timeline of the history of CSF research, which begins with Galen describing the ventricles, and Antonio Valsalva draining some dog's lumber sack.
Venkatesh is in good company, that of Hippocrates Galen and Cushing. The first opinion on the CSF is credited to Swedendorg, a 16th century theologian whose discussions of the "highly gifted juice" were published well over a century after his death. This of course represents an unforgivable departure from the usual agreement, where the reader is provided with a high quality reference which is relevant to their exam preparation. For that, Shahan et al (2021) or Seehusen et al (2003) are good and short, whereas Jurado & Walker (1990) is good but not short. And if one were after a much more extensive reference, one would end up going to something like Cerebrospinal Fluid in Clinical Practice (Irani, 2009), a 400-page diversion for the reader who really needs to know their CSF abnormalities back to front. Locally, the gifted juice is also explored in the CSF chapter from the First Part exam, where the focus is mostly on the basic sciences.
A normal-sized person has 125-150ml of CSF, and produces about 20-24ml of it per hour.
The choroid plexus secretes this clear acellular fluid by some mixture of ultrafiltration and active transport. Probably ultrafiltration has little role to play, because the concentration of electrolytes in the CSF is under fairly tight control and this would not occur if the choroid plexus dumbly pushed plasma through a filter. The active transport component of CSF production relies on the active transport of sodium and chloride, with water movement through aquaporins and leaky cellular junctions; the whole thing is rather complex and instead of getting carried away with ion channel diagrams I will merely reference an article which scrutinises this topic with exhausting attention to detail.

It is said that the rate of CSF production is about 0.4ml per minute. Thus, one can expect one's EVD output to be 24ml/hr if all of the produced CSF issues forth though the EVD rather than circulating around in a normal manner. In this fashion, one can expect a person to produce about 576ml of of CSF every day, which seems like quite a lot.
Essentially, this substance is plasma. There is one notable difference, however: it is the near-total absence of protein. This influences the concentration of the ions in the CSF. After all, who will contribute all that extra negative charge, in the absence of anionic protein? Certanly not the bicarbonate. The pH of the CSF very closely resembles the pH of plasma because the CO2 diffuses freely in and out of the CSF space, and undergoes the same conversion into HCO3-; there is perhaps a subtle difference in CSF HCO3- incomaprison to plasma because the CSF is devoid of all those helpful buffering proteins. But this is a digression. Early 1960s dog studies compared CSF electolytes to the electrolytes of plasma. Within the normal measurement error ranges, most of the cation concentrations were essentialy the same, with perhaps the tiniest bit less of potassium in the CSF.

Not so for the anions, obviously. Without albumin to donate anionic charge, the chloride concentration in the CSF is about 15-20mmol higher than in the plasma. The dog studies put it at 132mmol/L or so.
Also referred to by the excellent term proteinorachia, an elevated CSF protein is never good, and almost always abnormal in an important way. The blood-CSF barrier excludes protein almost completely. Indeed, there is about 100-200 times less protein in the CSF under normal conditions; so where the total serum protein may be 80g/L, the CSF protein will be 0.4g/L. Any increase of this value suggests that either something has gone terribly wrong with the blood brain barrier and protein is getting in from the blood, or (worse) something is either secreting it locally in the CNS or is degenerating so destructively that fragments of protein and being created as debris. The range of terrible things described by Blakeley & Irani (2009) is summarised below, using a tired but reliable mnemonic tool "VINDICATE" :
Contamination: One can imagine that additional protein in the CSF may have come from the plasma, as a result of some sort of unhappy meeting between blood and CSF. This may be the result of a proper intracranial haemorrhage, or it may be the result of a traumatic tap, in which case it should be viewed as a normal finding. Generally speaking, for every 1000 RBCs per microlitre, there should be an extra 0.01g/L of protein, which is not very much. An extremely bloodstained CSF could therefore be expected to have 50,000-100,000 RBCs per μl and therefore 0.5g-1.0/L protein.
Vascular compromise: apart from ICH, ischaemic stroke (including venous infarction) can cause a leak of protein from broken capillaries and dying cells (and then it takes one month to normalise)
Infection: obviously the most common finding, which
Neoplasm typically increases CSF protein by poor quality control over angiogenesis, where the CNS tumour creates numerous new vessels which have highly permeable endothelium. The result is an increased access of plasma proteins to the CNS. Also, CNS tumours can cause an obstruction to CSF flow, creating stragnation and protein concentration known as Froin's syndrome, which is likely to be the highest CSF protein concentration you may ever see. Jacobs et al (2024) reports cases where the CSF protein was higher than the plasma protein. It "coagulated within a few seconds", quoth they, sufficiently amazed that they took pictures of the glob at the bottom of the sample via. Conversely, a continuous CSF leak typically produces abnormally depressed CSF protein levels.
Drug-induced CSF protein leak is not an especially well-known phenomenon; the only drug that does this consistently seems to be alcohol, by disrupting the blood brain barrier (Kornhuber et al, 1987)
Idiosyncratic effects of selected diseases which remain unexplained include:
Congential abnormalities such as metachromatic leukodystrophy or galactosylceramide beta-galactosidase deficiency can cause raised CSF protein by a range of mechanisms perhaps too exotic to elaborate on in this chapter. More straightforward mechanisms are those related to neural tube defects and anything that produces congenital hydrocephalus.
Autoimmune inflammatory conditions are innumerable and the ones listed here are only a selection of easily memorable ones:
Trauma to the CNS can obviously rain protein into the CSF
Endocrine causes of elevated CSF protein seem to be limited to hypothyroidism and myxoedema coma, which is not reported very much (it seems limited to letters to editors and case reports).
Occaisonally one may have grounds to test the CSF for a specific protein. Those proteins, and those grounds, are:
| Protein | Associated conditions |
| Tau | Alzheimers disease, Parkinsons, frontotemporal dementia |
| Neuron-specific enolase | Creutzfeldt-Jakob disease |
| S-100 beta | CJD, MS |
| Beta-transferrin | CSF leak (i.e. this is used to identify a Mystery Fluid as CSF, if there is some confusion) |
| Cystatin C | Amyotropic lateral sclerosis |
| IgG | MS |
| IgM | CNS lymphoma |
| Transthyretin | Amyotropic lateral sclerosis |
| ACE | Sarcoidosis |
Glucose moves into the CSF by facilitate ransport, and is then sucked back out again by the walls of the CSF cisterns. All those cells eat it right up. Thus, the CSF glucose content is always somewhat lower than that of serum - the ratio is about 0.6. Thus, a patient with a BSL of 10mmol/L will be expected to have a CSF glucose of 6mmol/L.
As there are numerous cells, organisms and chemical processes which feed on glucose, so there are numerous reasons why the CSF glucose might be abnormally low.
Causes of low CSF glucose:
Of all these, the lowest glucose concentrations would be in bacterial meningitis. All those reproducing organisms tend to gobble up glucose at a rapid rate, and the CSF value is typically below 1.0 mmol/L
CSF glucose is usually normal in viral meningitis or encephalitis. Usually. Obviously, exceptions always exist. One would not hang their diagnosis purely on the CSF protein.
Having referred to this fluid as acellular, I must grudgingly accept that even in normal CSF some errant cells may be sneaking around. 4-5 RBCs per millilitre is said to be normal; anything more than 3 WCCs is generally abnormal.
Classically, it is said that a neutrophil-dominant WCC around 500 is suggestive of bacterial meningitis, and a monocyte-dominant WCC around 100 is more suggestive of viral meningitis.
However, there are really no fixed rules. Lets say you collect CSF too early in the course of bacterial meningitis- the WCC count may actually be quite normal, seeing as the CSF has not yet had time to change into frank pus.
Additionally, there is time-associated degradation. Let us consider a scenario where the CSF is allowed to brew quietly in the corner of the peripheral emegency department, waiting to be collected and taken by taxi to the nearest laboratory. Over the first few hours, a fair poportion of the WCCs will lyse, and defy detection. Another proportion will settle to the bottle of the plastic tube or stick to the walls. For this reason, one really needs to get the cell count done within 60 minutes or so.
In order to confuse things further, there is a certain amount of WCCs which is expected if there has been an intracranial bleed or traumatic tap. Generally speaking, for every 500-1500 RBCs, 1 leucocyte is permitted in the CSF. The figure changes somewhat for patients with EVDs -the mere presence of an EVD tends to stimulate a CSF pleocytosis, and the pragmatic intensivist will permit a larger proportion of white cells. Of course, this is an evidence-free zone. How much does one relax their standards for RBC/WCC ratio? Depends on how many episodes of ventriculitis one is prepared to ignore.
So lets hypothetically consider a patient recovering from a subarachnoid haemorrhage, with a CSF RCC of oh, say 30,000. This patient would therefore be expected to have a WCC around 60-180. Anything more than that could then be viewed as "CSF pleocytosis". Of course, in order to call it ventriculitis one would actually have to demonstrate an organism, but a rising white cell count in the CSF would certainly make you want to pull out the infected EVD.
This, of course, is a very crude approximation; but it stems from the general belief that any bleeding into the CSF is essentially just blood being diluted by CSF, an act which keeps the proportions of white cells and red cells intact. Reasoning in this way, one can arrive at a more mathematically correct method, comparing the ratio of cells in the CSF with the ratio of cells in the bloodstream. Dr Beer from the ventriculitis article describes this "cell index" as follows:

Under conditions of a totally sterile non-infectious CSF and blood mixture, the cell index should be 1.
In this fashion, one can predict what the CSF WCC should be no matter how deranged and bizarre the hematological abnormalities. Say the patient has a neutrophil count of 110,000 because of some sort of berzerk myeloproliferative disorder? No matter! Cell index should still be 1. Any increase in this index suggests that there are more than the expected amount of WCCs in the CSF, and so some sort of inflammatory process is taking place there.
So, what is causing this pleocytosis?
Causes of raised CSF granulocytes
Causes of raised CSF lymphocytes and monocytes
So, any damn thing, really.
No all of these are exactly routine, but its worth knowing about them.
A rises in CSF lactate can be the result of any damn thing, be it bacterial meningitis, acute brain injury, stroke... Its really not a specific marker of anything. Venkatesh's article examines some of its uses; seems as if it an be used to distinquish between viral and bacterial meningitis. This marker is not in routine use.
Lactate dehydrogenase rises in the CSF in response to non-specific cell injury. Generally speaking, CSF LDH levels are 10 times lower than those of serum. It is said that in bacterial meningitis the serum LDH levels are massively elevated, whereas in viral meningitis they are more modestly elevated or actually normal. How many more CSF tests do we need to diagnose bacterial meningitis? This one can be thrown into the same corner.
Creatine kinase in the brain is the result of neuronal breakdown, and there is some relationship between its level and the extent of brain damage. Naturally, the more brain tissue gets smooshed, the more CK it leaks, and the higher the CSF CK level. Now, the article I keep quoting actually presents CK levels which have been associated with certain degrees of injury, which might give one the impresson that CSF CK is somehow useful in prognostication. However, between the volume of smooshed brain and the quality of neurological outcome exists a very feeble relationship. I would be very reluctant to rest a family's hopes on this single biological marker, early in the course of a head injury.
There are very few proteins which are specific to the CSF, and which are absent from the plasma. β2 transferrin is one of these. It is the product of the normal β-transferrin which seeps into the CSF, and is then worked over by CNS neuraminidase. It can be useful in detecting the leakage of CSF. And lets face it, there are many circumstance during which we gather around a spot of wetness on the patients' pillow, and wonder whether that spot is CSF or just snot.
Sure, there are the traditional investigations. One can dribble the fluid into some gauze or absorbent tissue and watch for the "target sign", where the blood remains central while the CSF spreads outwards. Or one can collect some of the fluid and send it to the lab for some sort of biochemical confirmation of it being CSF. This, naturally, brings up delicate questions regarding the biochemical composition of saliva and nasal mucus. How much protein should there be? Chloride? Lactate? And are these parameters constant? Could there, even in some alternate universe, be a scenario where the biochemical composition of one's mucus is very similar to the composition of one's CSF?
Fortunately the existence of the β2 transferrin assay spares one the need to closely examine these questions.
Apart from having had their heads cut open, these patients face the peculiar experience of having a thin silicone rubber tube in their brain. This is ok for 3 or so days; thereafter, the risk of infection begins to increase exponentially. Unfortunately, the actual presence of such a brain tube tends to irritate the delicate brain parenchyma, causing an increase in CSF WCC and protein, making it difficult to diagnose such an infection.
The presence of fever tends to be the decisive feature; and of course there is always the CSF culture.
The SAH patient will have RBCs(obviously), boring old xanthochromia, as well as a decrease in the CSF glucose (because the RBCs have been metabolising it).
Late in the game these people develope a bit of a CSF lymphocytosis, but the real money is in the protein. A pathognomonic feature of the disease is a rise in CSF protein. Weirdly, critical illness polyneuropathy tends to have an increased CSF protein also, but not quite to the same level as GBS.
Somehow, epilepsy results in a leaky blood-brain barrier. The CSF is thus enriched with plasma protein (though not usually cells, though sometimes the CSF WCC is mildly elevated). A slight rise in CSF protein is therefore to be expected after prolonged seziures.
Jurado, Rafael, and H. Kenneth Walker. "Cerebrospinal fluid." Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition (1990).
Venkatesh, B., P. Scott, and M. Ziegenfuss. "Cerebrospinal fluid in critical illness." Critical care and resuscitation 2 (2000): 42-54.
Shahan, Brian, Edwin Y. Choi, and Gilberto Nieves. "Cerebrospinal fluid analysis." American family physician 103.7 (2021): 422-428.
Seehusen, Dean A., Mark M. Reeves, and Demitri A. Fomin. "Cerebrospinal fluid analysis." American family physician 68.6 (2003): 1103-1109.
Irani, David N. Cerebrospinal fluid in clinical practice. Elsevier Health Sciences, 2008.
Gupta, Tapisha. "Cerebrospinal Fluid Analysis in Infectious Disease." Pediatric Infectious Disease 4.2 (2022): 76-77.
Hegen, Harald, et al. "Guidelines on cerebrospinal fluid analysis." Cerebrospinal Fluid in Clinical Neurology (2015): 407-428.
SCHAIN, RICHARD J. "Cerebrospinal fluid and serum cation levels." Archives of Neurology 11.3 (1964): 330.
Deisenhammer, F., et al. "Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force." European journal of neurology 13.9 (2006): 913-922.
Tumani, H., et al. "S1 guidelines “lumbar puncture and cerebrospinal fluid analysis”(abridged and translated version)." Neurological Research and Practice 2 (2020): 1-28.
Deisenhammer, Florian, et al. "EFNS guidelines on disease‐specific CSF investigations." European journal of neurology 16.6 (2009): 760-e163.
Blakeley, Jaishri, and David N. Irani. "Approach to patient with abnormal cerebrospinal fluid protein Content." Cerebrospinal Fluid in Clinical Practice 32 (2009): 290.
POSNER, JEROME B., AUGUST G. SWANSON, and FRED PLUM. "Acid-base balance in cerebrospinal fluid." Archives of neurology 12.5 (1965): 479.
Jacobs, Lucas, et al. "Froin’s Syndrome: A Comprehensive Review of the Literature and the Addition of Two New Cases." Neurology International 16.5 (2024): 1112-1121.
Brown, P. D., et al. "Molecular mechanisms of cerebrospinal fluid production."Neuroscience 129.4 (2004): 955-968.
Sharma, Khema R., et al. "Demyelinating neuropathy in diabetes mellitus." Archives of Neurology 59.5 (2002): 758-765.
Kornhuber, Johannes, et al. "Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man." Neuroscience letters 79.1-2 (1987): 218-222.
Steele, Russell W., et al. "Leukocyte survival in cerebrospinal fluid." Journal of clinical microbiology 23.5 (1986): 965-966.
Frost, Natasha, Michael S. Lee, and Patrick Sweeney. "Myxedema, papilledema, and elevated CSF protein." Neurology 63.4 (2004): 754-755.
Beer, R., P. Lackner, and B. Pfausler. "Nosocomial ventriculitis and meningitis in neurocritical care patients." Journal of neurology 255.11 (2008): 1617-1624.
Zaret, Deborah L., et al. "Immunofixation to quantify beta 2-transferrin in cerebrospinal fluid to detect leakage of cerebrospinal fluid from skull injury."Clinical chemistry 38.9 (1992): 1908-1912.
Swedenborg, E. "The Brain." Considered Anatomically, Physiologically and Phylosopically.(translated and edited by RL Tafel), London (1887).
Hajdu, Steven I. "Discovery of the cerebrospinal fluid." Annals of Clinical & Laboratory Science 33.3 (2003): 334-336.